Drugs / Botulinum Toxin Type A (BoNT-A)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT06811142 Comparator | Jan 2025 → Feb 2027 expected | stroke disorder | Mexican Social Security Institute | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Botulinum Toxin Type A (BoNT-A) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06811142 ↗ |